Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulators | Patent Publication Number 20220315590
US 20220315590 A1Patent NumberUS 11993587 B2
Application Number17618068
Filled DateJun 12, 2020
Priority DateJun 14, 2019
Publication DateOct 6, 2022
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsHeather Coate
Heather COATE
Curt DVORAK
Curt Dvorak
Heather COATE
Curt DVORAK
Curt Dvorak
![Patent Prosecution report image](/_next/image?url=https%3A%2F%2Fpatexia-data.s3.amazonaws.com%2Fconnect%2F65256ba2e3fa03282001bdac%2F280_c4899fec3f1140f6f1ec05c01211cc01.jpg&w=384&q=75)
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.